Baylor College of Medicine Department of Urology

08/15/2025

Join us in recognizing and celebrating our outstanding GME professionals for GME Professionals Day! Thank you for all you do to advance our educational mission!

08/05/2025

We’re proud to share that Dr. Christopher Smith has been appointed as the Urological Surgery Consultant to the Surgeon General of the U.S. Army. He will serve a four-year role that began on August 1.

Thank you for your leadership and service, Dr. Smith!

08/01/2025

Join the leadership and residents from the Scott Department of Urology for an overview of the program and Q&A with current residents.

REGISTER TODAY: bit.ly/2025SDUOpenHou…

08/01/2025

Dr. Wesley Mayer and his peers have a clinical trial published and featured on the cover of the August edition of the Journal Of Urology.

Read more at auajournals.org/doi/10.1097/JU…

07/30/2025

Dr. Seth Lerner joined FOX 26 to discuss Bladder Cancer causes, signs, and prevention.

For more information about Bladder Cancer, visit bit.ly/40EEmqj.

07/28/2025

Have you or a loved one considered s***m banking? Learn more about what it is and why s***m banking is one of the many procedures we offer to our patients.

07/28/2025

New research suggests that building muscle mass can help combat erectile dysfunction. Here's how that works.

07/18/2025

Meet our Male Reproductive Medicine and Surgery fellow! Drop a 👋 and welcome them to Baylor College of Medicine!

07/17/2025

The Scott Department of Urology welcomed Dr. Tobias Kohler to Houston for an informative lecture on the use of Anabolic Steroids in men.

.clinic.urology

07/08/2025

Dr. Jeffrey Jones and Dr. Jennifer Taylor had an integral role in bringing a revolutionary new immunotherapy treatment for bladder cancer to the Michael E. DeBakey VA Medical Center. Army veteran Ervin Green was the first to receive ANKTIVA®, a therapy that harnesses the power of the immune system to target and destroy cancer cells.

07/08/2025

Great work by our very own Dr. Jennifer Taylor and Dr. Jeffrey Jones!

In a groundbreaking move for Veterans' healthcare, doctors at the Michael E. DeBakey VA Medical Center recently began offering a revolutionary new immunotherapy treatment for bladder cancer.

Army Veteran Ervin Green (left) was the first to receive ANKTIVA®, a therapy that harnesses the power of the immune system to target and destroy cancer cells.

“The immune stimulation in ANKTIVA® represents a significant advancement in treatment options for veterans,” said Dr. Jeffrey Jones (right).

“New immunotherapies are crucial for improving outcomes in Veterans with cancer, and I’m proud that Houston VA is leading the way in making it available to our patients.”

Read more! https://www.va.gov/houston-health-care/stories/houston-va-pioneers-new-immunotherapy-for-veterans-battling-bladder-cancer/

07/02/2025

Meet our newest trainees! As residency programs kick off across the country, we’re excited to cheer them on and see all they accomplish. The future is bright!